203 related articles for article (PubMed ID: 17590442)
1. Blocking lymphotoxin beta receptor signalling exacerbates acute DSS-induced intestinal inflammation--opposite functions for surface lymphotoxin expressed by T and B lymphocytes.
Jungbeck M; Stopfer P; Bataille F; Nedospasov SA; Männel DN; Hehlgans T
Mol Immunol; 2008 Jan; 45(1):34-41. PubMed ID: 17590442
[TBL] [Abstract][Full Text] [Related]
2. Lymphotoxin-beta receptor activation on macrophages ameliorates acute DSS-induced intestinal inflammation in a TRIM30α-dependent manner.
Wimmer N; Huber B; Wege AK; Barabas N; Röhrl J; Pfeffer K; Hehlgans T
Mol Immunol; 2012 Jun; 51(2):128-35. PubMed ID: 22437076
[TBL] [Abstract][Full Text] [Related]
3. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein.
Columba-Cabezas S; Griguoli M; Rosicarelli B; Magliozzi R; Ria F; Serafini B; Aloisi F
J Neuroimmunol; 2006 Oct; 179(1-2):76-86. PubMed ID: 16870269
[TBL] [Abstract][Full Text] [Related]
4. Lymphotoxin-β receptor activation by lymphotoxin-α(1)β(2) and LIGHT promotes tumor growth in an NFκB-dependent manner.
Daller B; Müsch W; Röhrl J; Tumanov AV; Nedospasov SA; Männel DN; Schneider-Brachert W; Hehlgans T
Int J Cancer; 2011 Mar; 128(6):1363-70. PubMed ID: 20473944
[TBL] [Abstract][Full Text] [Related]
5. The Tumor Necrosis Factor Superfamily Members TNFSF14 (LIGHT), Lymphotoxin β and Lymphotoxin β Receptor Interact to Regulate Intestinal Inflammation.
Giles DA; Zahner S; Krause P; Van Der Gracht E; Riffelmacher T; Morris V; Tumanov A; Kronenberg M
Front Immunol; 2018; 9():2585. PubMed ID: 30524422
[TBL] [Abstract][Full Text] [Related]
6. The lymphotoxin β receptor is a potential therapeutic target in renal inflammation.
Seleznik G; Seeger H; Bauer J; Fu K; Czerkowicz J; Papandile A; Poreci U; Rabah D; Ranger A; Cohen CD; Lindenmeyer M; Chen J; Edenhofer I; Anders HJ; Lech M; Wüthrich RP; Ruddle NH; Moeller MJ; Kozakowski N; Regele H; Browning JL; Heikenwalder M; Segerer S
Kidney Int; 2016 Jan; 89(1):113-26. PubMed ID: 26398497
[TBL] [Abstract][Full Text] [Related]
7. Lymphtoxin beta receptor-Ig ameliorates TNBS-induced colitis via blocking LIGHT/HVEM signaling.
An MM; Fan KX; Zhang JD; Li HJ; Song SC; Liu BG; Gao PH; Zhou Q; Jiang YY
Pharmacol Res; 2005 Sep; 52(3):234-44. PubMed ID: 15925518
[TBL] [Abstract][Full Text] [Related]
8. TNF and lymphotoxin beta cooperate in the maintenance of secondary lymphoid tissue microarchitecture but not in the development of lymph nodes.
Kuprash DV; Alimzhanov MB; Tumanov AV; Anderson AO; Pfeffer K; Nedospasov SA
J Immunol; 1999 Dec; 163(12):6575-80. PubMed ID: 10586051
[TBL] [Abstract][Full Text] [Related]
9. Lymphotoxin-beta receptor signalling regulates cytokine expression via TRIM30α in a TRAF3-dependent manner.
Wimmer N; Heigl U; Klingseisen L; Schneider-Brachert W; Hehlgans T
Mol Immunol; 2013 May; 54(1):40-7. PubMed ID: 23220069
[TBL] [Abstract][Full Text] [Related]
10. Lymphotoxin-beta receptor immune interaction promotes tumor growth by inducing angiogenesis.
Hehlgans T; Stoelcker B; Stopfer P; Müller P; Cernaianu G; Guba M; Steinbauer M; Nedospasov SA; Pfeffer K; Männel DN
Cancer Res; 2002 Jul; 62(14):4034-40. PubMed ID: 12124338
[TBL] [Abstract][Full Text] [Related]
11. Lymphotoxin β receptor activation on macrophages induces cross-tolerance to TLR4 and TLR9 ligands.
Wimmer N; Huber B; Barabas N; Röhrl J; Pfeffer K; Hehlgans T
J Immunol; 2012 Apr; 188(7):3426-33. PubMed ID: 22357629
[TBL] [Abstract][Full Text] [Related]
12. Activation of the lymphotoxin-beta receptor induces NFkappaB-dependent interleukin-6 and MIP-2 secretion in mouse fibrosarcoma cells.
Hehlgans T; Müller P; Stopfer P; Männel DN
Eur Cytokine Netw; 2003; 14(2):103-7. PubMed ID: 12957791
[TBL] [Abstract][Full Text] [Related]
13. The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function.
Wang J; Foster A; Chin R; Yu P; Sun Y; Wang Y; Pfeffer K; Fu YX
Eur J Immunol; 2002 Jul; 32(7):1969-79. PubMed ID: 12115617
[TBL] [Abstract][Full Text] [Related]
14. Expression of lymphotoxin beta governs immunity at two distinct levels.
Junt T; Tumanov AV; Harris N; Heikenwalder M; Zeller N; Kuprash DV; Aguzzi A; Ludewig B; Nedospasov SA; Zinkernagel RM
Eur J Immunol; 2006 Aug; 36(8):2061-75. PubMed ID: 16841297
[TBL] [Abstract][Full Text] [Related]
15. Lymphotoxin-β receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells.
Satoh-Takayama N; Lesjean-Pottier S; Sawa S; Vosshenrich CA; Eberl G; Di Santo JP
Eur J Immunol; 2011 Mar; 41(3):780-6. PubMed ID: 21341264
[TBL] [Abstract][Full Text] [Related]
16. Blocking lymphotoxin-beta receptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression and leucocyte margination in chronic DSS-induced colitis.
Stopfer P; Obermeier F; Dunger N; Falk W; Farkas S; Janotta M; Möller A; Männel DN; Hehlgans T
Clin Exp Immunol; 2004 Apr; 136(1):21-9. PubMed ID: 15030510
[TBL] [Abstract][Full Text] [Related]
17. Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs.
Wilhelm P; Riminton DS; Ritter U; Lemckert FA; Scheidig C; Hoek R; Sedgwick JD; Körner H
Eur J Immunol; 2002 Jul; 32(7):1993-2003. PubMed ID: 12115620
[TBL] [Abstract][Full Text] [Related]
18. Biology and signal transduction pathways of the Lymphotoxin-αβ/LTβR system.
Remouchamps C; Boutaffala L; Ganeff C; Dejardin E
Cytokine Growth Factor Rev; 2011; 22(5-6):301-10. PubMed ID: 22152226
[TBL] [Abstract][Full Text] [Related]
19. Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues.
Murphy M; Walter BN; Pike-Nobile L; Fanger NA; Guyre PM; Browning JL; Ware CF; Epstein LB
Cell Death Differ; 1998 Jun; 5(6):497-505. PubMed ID: 10200501
[TBL] [Abstract][Full Text] [Related]
20. Immediate lymphotoxin beta receptor-mediated transcriptional response in host defense against L. monocytogenes.
Kutsch S; Degrandi D; Pfeffer K
Immunobiology; 2008; 213(3-4):353-66. PubMed ID: 18406380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
